bromfenac sodium and its Impurities
The FDA and European approvals for Bromfenac Sodium are for use one day before and two weeks following cataract surgery for the treatment of ocular inflammation and pain. It is a nonsteroidal anti-inflammatory drug.. Reference standards of Bromfenac Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
(12-Oxo-5,6,11,12-tetrahydrobenzo[6,7]azepino[4,3-b]indole-4,10-diyl)bis((4-bromophenyl)methanone)
(12-Oxo-5,6,11,12-tetrahydrobenzo[6,7]azepino[4,3-b]indole-4,10-diyl)bis((4-bromophenyl)methanone)
Catalogue No.:PA 02 0471001
CAS :
1644279-16-2
Molecular Formula : C30H18Br2N2O3
Molecular Weight : 614.29
